Showing results (221-230 of 3,330) with videos related to
Sort By:
Pageof 333
Journal of the American Chemical Society|October 11, 2001
Asymmetric mono-oxazine: an inevitable product from Mannich reaction of benzoxazine dimersA Laobuthee, S Chirachanchai, H Ishida, et al.Nihon Rinsho. Japanese Journal of Clinical Medicine|June 1, 1997
[Clonal deletion and clonal anergy as the mechanism of self-tolerance induction]H Ota, H Yanagida, H Dobashi, et al.Nihon Rinsho. Japanese Journal of Clinical Medicine|June 1, 1997
[An imbalance between Th1 and Th2-like cytokines in patients with autoimmune diseases--differential diagnosis between Th1 dominant autoimmune diseases and Th2 dominant autoimmune diseases]H Ishida, H Ota, H Yanagida, et al.Abdominal Imaging|March 1, 1994
Macroscopic intrahepatic portal-hepatic venous shunt not associated with chronic hepatic diseaseH Naganuma, H Ishida, M Niizawa, et al.Carbohydrate Research|April 25, 1990
Stereoselective synthesis of sialyl-lactotetraosylceramide and sialylneolactotetraosylceramideA Kameyama, H Ishida, M Kiso, et al.Chemical & Pharmaceutical Bulletin|June 1, 1989
Studies on the antihemostatic substances in herbs classified as hemostatics in traditional Chinese medicine. I. On the antihemostatic principles in Sophora japonica LH Ishida, T Umino, K Tsuji, et al.Nihon Rinsho. Japanese Journal of Clinical Medicine|September 29, 1998
[A study on androgen deprivation therapy prior to radical prostatectomy with special reference to the tumor volume]T Hachiya, J Nogaki, H Ishida, et al.Analytical Chemistry|August 21, 2001
Chemical plume tracking. 2. Multiple-frequency modulationT Kikas, P Janata, H Ishida, et al.Carbohydrate Research|October 12, 2000
Systematic synthesis of sulfated sialyl-alpha-(2 --> 3)-neolactotetraose derivatives and their acceptor specificity for an alpha-(1 --> 3)-fucosyltransferase (Fuc-TVII) involved in the biosynthesis of L-selectin ligandK Fukunaga, K Shinoda, H Ishida, et al.Carbohydrate Research|April 30, 1996
Systematic synthesis of alpha-sialyl-(2 --> 3)- and -(2 --> 6)-isoglobopentaosylceramides (V3Neu5AciGb5Cer and V6Neu5AciGb5Cer)H Ishida, R Miyawaki, M Kiso, et al.Pageof 333